Symbols

NERV

Minerva·NASDAQ

--(--)

NERV Profile

Minerva Neurosciences, Inc.

A clinical-stage biopharmaceutical company focused on the therapies to treat central nervous system disorders

Industry

Pharmaceutical

Established Date

04/23/2007

Listing Date

07/01/2014

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.minervaneurosciences.com

Security Type

Common stock

Office address

1500 District Avenue, Burlington, MA 01803

Business

Introduction

Minerva Neurosciences, Inc., was incorporated under the laws of the State of Delaware on April 23, 2007. The Company is a clinical-stage biopharmaceutical company focused on the development and commercialization of patented product candidates for central nervous system diseases. Its lead drug candidate, roluperidone, is in development for the treatment of negative symptoms of schizophrenia, with Phase 3 confirmatory trials planned.